1. Home
  2. BCBP vs STTK Comparison

BCBP vs STTK Comparison

Compare BCBP & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BCB Bancorp Inc. (NJ)

BCBP

BCB Bancorp Inc. (NJ)

HOLD

Current Price

$9.97

Market Cap

139.1M

Sector

Finance

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$7.68

Market Cap

569.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCBP
STTK
Founded
2000
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.1M
569.1M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
BCBP
STTK
Price
$9.97
$7.68
Analyst Decision
Hold
Buy
Analyst Count
2
6
Target Price
$10.00
$10.00
AVG Volume (30 Days)
95.4K
436.3K
Earning Date
04-21-2026
05-01-2026
Dividend Yield
3.19%
N/A
EPS Growth
N/A
53.02
EPS
N/A
N/A
Revenue
N/A
$1,000,000.00
Revenue This Year
$85.26
N/A
Revenue Next Year
$6.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.31
$0.71
52 Week High
$10.25
$8.33

Technical Indicators

Market Signals
Indicator
BCBP
STTK
Relative Strength Index (RSI) 71.59 68.59
Support Level $7.55 $1.85
Resistance Level N/A N/A
Average True Range (ATR) 0.30 0.51
MACD 0.03 0.01
Stochastic Oscillator 76.82 65.79

Price Performance

Historical Comparison
BCBP
STTK

About BCBP BCB Bancorp Inc. (NJ)

BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: